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Replication-defective vectors based on an infectious molecular clone of human foamy virus (HFV) were constructed by
deletion and replacement of the accessory genes with expression cassettes for puromycin-resistance and b-glucouronidase.
Cell lines which produced in excess of 105 helper virus-free transducing units/ml were generated by trans-complementation
of the replication defect using a BHK-21-derived cell line expressing the Bel-1 transactivator. Vectors based on the HFV
genome may provide useful alternatives to existing retroviral vectors. q 1997 Academic Press
INTRODUCTION structs were designed to minimize the probability that
replication-competent viruses would be generated by re-
The foamy viruses are a distinct group of retroviruses combination in vector producing cell lines.
which, unlike lentiviruses and oncoviruses, have never Like other complex retroviruses (Cullen, 1992), HFV
been conclusively associated with natural infection (Ali encodes a transcriptional transactivator (Bel-1) which is
et al., 1996) or with any disease either in human or essential for LTR driven gene expression and for virus
animals (Weiss 1993; Schweizer et al., 1995). While the replication (Keller et al., 1991; Rethwilm et al., 1991; Lo¨-
genome sequence of four isolates has been determined chelt et al., 1991; Baunach et al., 1993). In contrast, the
(Flugel et al., 1987; Maurer et al., 1988; Kupiec et al., bel-2 and bel-3 open reading frames are dispensible for
1991; Renne et al., 1992; Herchenro¨der et al., 1994) and HFV replication in vitro (Baunach et al., 1993; Yu and
infectious molecular clones derived from human and Lineal, 1993). Therefore, a BHK-21-derived cell line (engi-
chimpanzee isolates have been constructed (Rethwilm neered to stably express Bel-1) was used in a similar
et al., 1990; Lo¨chelt et al., 1991; Herchenroder et al., manner to the adenovirus vector 293 helper cell line (Per-
1995), this genera of viruses remains the least investi- ricaudet and Perricaudet, 1995); i.e., to trans-complement
gated of the Retroviridae. defective HFV in which the bel genomic region was re-
Retroviral vectors have been exploited to study various placed with marker genes. Specifically, a vector provirus
aspects of the retrovirus life cycle, including reverse tran- was constructed which replaced the bel-1 and bel-2
scription and RNA packaging and are useful vehicles for genes with a puromycin-resistance gene under the tran-
gene transfer both in vitro and in vivo (reviewed by Miller, scriptional control of the SV40 early promoter. A second
1992). However, the unique replication strategy of foamy vector, containing a gusA gene (encoding the bacterial
viruses (Rethwilm, 1996) has so far not allowed for the enzyme b-glucuronidase) was similarly constructed. Bel-
development of such packaging cells or vectors. In this 1 expressing cells were transfected with vector provi-
study, replication-defective genomes derived from an in- ruses to generate cell lines producing virus particles ca-
fectious molecular clone of HFV (Rethwilm et al., 1990) pable of completing only the early stages of the retroviral
are described. Such retroviral vectors would serve as life cycle, while expression of transduced genes could
useful starting reagents for the mapping of minimal cis- be monitored by antibiotic selection or histochemical
acting sequences required for genome transfer. To this staining.
end, vector genomes were constructed which minimally
disrupted the wild-type HFV sequence, while rendering
MATERIALS AND METHODSgenomes replication-defective. Furthermore, vector con-
Molecular construction
1 Current address: Howard Hughes Medical Institute, Duke Univer-
A plasmid, pRFF62, which contains the HFV LTRs, gag,sity Medical Center, Durham, North Carolina 27710.
pol, and env genes with bel-1 and bel-2 reading frames2 To whom correspondence and reprint requests should be ad-
dressed. Fax: //171 725 6645. destroyed (Fig. 1) was constructed. An SV40 promoter-
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FIG. 1. HFV-derived vector constructs. Replication-defective vectors were constructed, as described in the text. The scale indicates nucleotide
position in kilobases. Hatching indicates heterologous genes under the transcriptional control of an SV40 early promoter inserted into the bel
genomic region. Solid shaded regions at the 3* end of env and 5* end of bel-1 indicate sequences which are shared with the Bel-1 expression
construct in BHK/Bel-1 cells.
puromycin-resistance gene (puro) cassette was first am- replaced by a poly-linker (Schmidt and Rethwilm, 1995)].
An EcoRI fragment of pBabegusA consisting of the SV40plified from an MLV vector containing plasmid, pBabe-
puro (Morgenstern and Land, 1990) using polymerase promoter and the gusA gene was inserted into the EcoRI
sites of the modified p3*komb-V1 and a clone with thechain reaction (PCR) primers which incorporated BglII
sites (underlined) into each end of the amplicon (TAC- SV40 gusA cassette in direct orientation identified. This
plasmid was digested with KpnI and AatII and a KpnI –GTAGATCTTCGCCAGCACAGTGGT and TTACTAGAT-
CTAGCTTGCCAAACCTAG). This PCR product was di- AatII fragment of p5*komb (Rethwilm et al., 1990) con-
taining the 5* LTR, gag, pol, and env sequences wasgested with BglII and inserted into BamHI and BglII di-
gested p3*komb, which contains sequences from the 3* inserted to reconstitute the complete vector genome,
pHSG11 (Fig. 1).end of the env gene, bel genes, and the 3* LTR (Rethwilm
et al., 1990). A clone with the insert in direct orientation
Generation of BHK/Bel-1 cellsrelative to the viral coding sequences was identified. An
NheI fragment consisting of the 3* end of the env gene, The bel-1 gene containing 1.05-kb SspI fragment of
the 5* end of the bel-1 gene, the SV40 puro cassette, pHSRV1 (Rethwilm et al., 1990, 1991) was inserted into
and viral sequences 3* of the BglII site was exchanged the EcoRI site of the retroviral vector pLEN (Adam and
for the equivalent fragment of pHSRV1 which contains Miller, 1991) by blunt-end ligation. The resulting plasmid,
the infectious HFV genome (Rethwilm et al., 1990). The pLENbel-1, was transfected into the ecotropic packaging
final RFF62 vector genome is depicted in Fig. 1. cell line GP/E-86 (Markowits et al., 1988) and cells were
A second vector plasmid, pHSG11, containing the HFV selected in 1 mg/ml G418. BHK-21 cells were transduced
LTRs, gag, pol, and env genes with bel-1, bel-2, and bel- with supernatant from the bulk GP/E-86/pLENbel-1 cells
3 reading frames destroyed was constructed. A HindIII – and selected with 0.5 mg/ml G418. Single cell clones
NarI fragment of pGUS358NS (Clontech) which includes were established from the G418-resistant cells by limiting
the complete Escherichia coli gusA gene was inserted dilution and screened by indirect immunofluorescence
in place of the puro gene into HindIII- and ClaI-digested using a Bel-1 reactive rabbit antiserum, as previously
pBabepuro to create pBabegusA. In addition, an EcoRI described (Baunach et al., 1993). The BHK/Bel-1 clone
site was inserted into to the SmaI site of p3*komb-V1 [a #28 was used for all further experiments and was charac-
terized as follows (data not shown). Cell clone #28modification of p3*komb with bel-2 and bel-3 sequences
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showed exclusively nuclear staining with Bel-1 antiserum Dark blue b-glucuronidase-positive cells were scored
after overnight incubation at 377.in immunofluorescence. In immunoblot a protein of 36
kDa apparent molecular weight which reacted with Bel-
1 antiserum was detected in cellular lysates prepared Assays for helper virus
from BHK/Bel-1#28, but not parental BHK-21 cells. South-
BHLL cells (Bieniasz et al., 1995a) are BHK cells whichern blot analysis revealed one copy of the bel-1 expres-
contain an integrated lacZ gene under the transcriptionalsion vector per cellular genome. Reporter gene assays
control of the HFV U3 promoter and, thus, form b-galac-using an HFV LTRcat construct (Erlwein and Rethwilm,
tosidase-positive foci on infection with replication-com-1993) demonstrated the functionality of the integrated
petent HFV. To detect recombinant replication-compe-bel-1 gene.
tent helper-virus, BHLL cells were seeded at 105 cells/
well in 6-well plates and on the following day each wellProduction of replication-defective viruses
was inoculated with a 1-ml aliquot of filtered supernatant
BHK/Bel-1 cells were transfected using lipofectamine harvested from RFF62 or HSG11 producing cells. Four
with 20 mg pRFF62 or 20 mg pHSG11 and 1 mg pPUR hours later 2 ml fresh medium was added and the cells
(Clontech). Forty-eight hours posttransfection cells were cultured for a further 48 hr. Cells were then fixed and
trypsinized and serially diluted in medium containing 2.5 stained for expression of b-galactosidase, as described
mg/ml puromycin. Each dilution was distributed in the previously (Bieniasz et al., 1995a). Alternatively, 2 1 104
wells of 96-well plates (one complete plate per dilution). BHK-21 or BHK/Bel-1 cells were seeded in 24-well plates
Selective medium was replaced every 3–4 days. After and the following day inoculated with 0.5-ml aliquots of
10–14 days, cells were harvested from wells which con- 10-fold serially diluted vector supernatants. These cells
tained single colonies. These colonies were individually were cultured for 48 hr and either immunoperoxidase
expanded in 24-well plates (6 colonies in the case of stained using an HFV-positive human serum, or pas-
RFF62 and 10 colonies in the case HSG11/pPUR), and saged in growth medium in the presence or absence
each clone screened for viral antigen expression by im- of 2.5 mg/ml puromycin. After 1, 3, 5, and 7 passages
munoperoxidase staining with an HFV-positive human supernatants were harvested and used to inoculate fresh
serum, as previously described (Bieniasz et al., 1995a). BHK-21 cells. These cells were assayed for secondary
In addition, pHSG11/pPUR transfectants were screened vector transfer by selection in puromycin or by b-gluc-
for b-glucuronidase expression by 5-bromo-4-chloro-3- uronidase staining, as appropriate.
indolyl b-D-galactopyranoside/Nitroblue tetrazolium (X-
gluc/NBT) staining, as described below. Clones which RESULTS
were 100% antigen-positive and, where appropriate, b-
Stable cell lines producing replication-defectiveglucuronidase-positive were assayed for transfer of puro-
HFV vectorsmycin-resistance or b-glucuronidase expression to BHK-
21 cells. To harvest vector stocks, producer cells were
Transient transfection of BHK/Bel-1 cells with either
seeded in 150-cm2 flasks and grown to confluence. The
pRFF62 or pHSG11 resulted in HFV antigen expression,
medium was then replaced with nonselective medium
as detected by immunoperoxidase staining. However,
and the supernatant harvested 24 hr later, filtered (0.4
this did not result in a spreading infection, as predicted.
mm), aliquoted, and stored at 0707 or in liquid nitrogen.
Over several passages the frequency of antigen-positive
cells remained low, no cytopathic effect (CPE) was ob-Transduction of cells with HFV vectors
served, and infection could not be reproducibly transmit-
ted to fresh BHK/Bel-1 cells (data not shown). Presum-BHK-21 cells were seeded in 24-well plates at 2 1 104
cells/well the day before infection. Vector stocks were ably the bulk of BHK/Bel-1 cells which took up vector
DNA during transient transfection did not produce suffi-serially diluted 10-fold and 300 ml was inoculated into
each well. The following day 500 ml of fresh medium cient virus to establish a spreading infection, i.e., the rate
of proliferation of cells which did not express vector waswas added. Forty-eight hours after inoculation, RFF62-
transduced cells were trypsinized and transferred to 6- greater than that of cells which did, and greater than
their rate of infection. This may have been due to lowwell plates containing growth medium and 2.5 mg/ml pu-
romycin. Puromycin-resistant colonies were assayed level Bel-1 expression in BHK/Bel-1 cells. Puromycin se-
lection and simultaneous cloning of transfected cells wasafter 10–14 days. HSG11 transduced cells were washed
once with PBS and fixed for 10 min at room temperature carried out in order to isolate high titer producing cell
clones, thereby preventing their loss due to outgrowth ofwith 1% formaldehyde/0.2% glutaraldehyde in PBS. After
three washes with PBS, 0.4 mm filtered b-glucuronidase cells in the culture which did not take up DNA during
transfection.substrate solution (0.5 mg/ml X-gluc, 1 mg/ml NBT, 0.05%
Triton X-100 in 100 mM Tris–HCl, pH 7.5) was added. Thus, directly following transfection, producer cell
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lines were cloned in 96-well plates in the presence of 2.5 and HSG11/11N) produced low titers of replication-com-
petent virus. In contrast, when BHK/Bel-1 cells were usedmg/ml puromycin. By this method, 6 RFF62-transfected
clones and 10 HSG11/pPUR-transfected clones which as target cells for RFF62 or HSG11, viral antigen-positive
cells could be detected by immunoperoxidase stainingremained viable on expansion in 24-well plates were
isolated. After immunoperoxidase and X-gluc/NBT stain- (Table 1, column D).
Although the HSG11 titers obtained using BHK/Bel-1ing, 4 pRFF62 and 6 pHSG11/pPUR transfectants were
identified which were 100% antigen-positive and, where target cells were lower than those obtained using BHK-
21 cells (Table 1, columns B and C), this was also theappropriate, b-glucuronidase-positive (Figs. 2A–2D). Al-
though the cell clones demonstrated varying levels of case for wild-type HFV (Table 1, columns D and E),
indicating that this was an inherent property of the BHK/spontaneous cell fusion, they could be repeatedly pas-
saged without obvious cell death. Thus, these clones Bel-1 cell line, and was not a vector-specific phenome-
non. Where examined, the titers were similar when BHK/were further analyzed for production of RFF62 and
HSG11 virus vectors. Bel-1 cells were used as targets for the HSG11 vector,
and either immunoperoxidase staining or X-gluc/NBT
Transduction of puro and gusA genes staining as a measure of infectivity (Table 1, column C
and D).Initially, supernatant fluid from the four RFF62 producer
Overall, these results indicate that the vector genomesclones and six HSG11 producer clones were screened for
were transferred in largely intact form, with rare genera-marker gene transduction. This was done by inoculation of
tion of replication competent helper virus by recombina-BHK-21 cells in 24-well plates with 300 ml of undiluted,
tion in BHK/Bel-1 cells.filtered supernatants, as described under Materials and
Methods. On the basis of visual examination of puromycin-
Requirement for Bel-1 expression in trans forresistant colonies or X-gluc/NBT-stained cells, two RFF62
secondary vector transferproducer clones and four HSG11 producer clones which
produced the highest vector titers were selected for further While immunoperoxidase staining and BHLL assays
analysis. End-point titrations were carried out using are both sensitive and specific for replication-competent
assays designed to detect production of virions containing virus arising by recombination, negative results in these
replication-defective vector genomes or recombinant rep- experiments do not exclude the possibility that low titers
lication-competent genomes (Table 1). Cell-free transduc- of vector might be produced by transduced Bel-1-nega-
tion of the gusA gene to fresh BHK-21 cells is shown in tive BHK-21 cells (via basal transcription directed by a
Figs. 2E and 2F. The titer of puro-transducing virus in the non-trans-activated LTR). Therefore, secondary transfer
supernatant of the two RFF62 producer cell lines was 1– of puromycin-resistance or b-glucuronidase expression
2 1 105 colony forming units/ml when assayed on BHK- was attempted: BHK-21 cells were inoculated with 105
21 cells (Table 1, column A). Similar titers of gusA-trans- CFU of RFF62 or 105 FFU of HSG11 (from RFF62/2N and
ducing virus (5 1 104 –3 1 105) were detected in the HSG11/22N producer clones, respectively) and after 1,
supernatant of the four HSG11 producer clones (Table 3, 5, and 7 passages either in the presence (for RFF62
1, column B). Successful transduction was achieved in transduced cells only) or absence of puromycin selection
different cell lines, for example, human embryonic lung culture supernatants harvested for secondary transfer to
(Hel), Hela, and a human rhabdomyosarcoma line (RD) BHK-21 cells. In neither case was secondary transfer
(data not shown). of vector genomes demonstrable (vector titer of 1). In
contrast, when Bel-1 was provided in trans (by inocula-
Helper virus detection and requirement for Bel-1
tion of BHK/Bel-1 cells with RFF62 or HSG11 vectors)
expression in trans for viral gene expression
secondary transfer of puro and gusA was readily demon-
strated. Although this secondary transfer was inefficientRFF62 and HSG11 stocks were routinely assayed for
the presence of helper virus by inoculation of BHLL cells. with unselected, vector inoculated BHK/Bel-1 cells (pro-
ducing vector titers of 60 and 120 after inoculation withAlternatively, transduced BHK-21 cells were assayed for
viral antigen expression by immunoperoxidase staining. RFF62 and HSG11, respectively), selection of RFF62-
transduced BHK/Bel-1 cells (pooled puromycin-resistantIn several cases, replication-competent virus was not
detected by immunoperoxidase staining or BHLL assays colonies) resulted in secondary transfer titers in excess
of 104 CFU/ml.(Table 1, columns E and F). However, two clones (RFF62T
FIG. 2. HFV vector producing cell lines and Transduction of BHK-21 with the gusA gene using the HSG11 vector. Immunoperoxidase staining of
BHK/Bel-1 cells (A) and the RFF62/2N producer clone (B) using an HFV-positive human serum. X-gluc/NBT staining of BHK/Bel-1 cells (C) and the
HSG11/9S producer clone (D); BHK-21 cells (2 1 104/well in 24-well plates) were mock inoculated (E) or inoculated with 100 ml filtered supernatant
from the HSG11/22N clone (F) and assayed for gusA transduction by X-gluc/NBT staining 48 hr postinoculation.
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TABLE 1
Transfer of puro and gusA Genes and Assays for Helper Virus
Virus/vector titer in supernatants taken from producer cell clones (measured using BHK-21, BHK/Bel-1, or BHLL target cells)
Virus/vector A B C D E F
virus/vector Puromycin-resistant b-glucuronidase/ b-glucuronidase/ Immunoperoxidase/ Immunoperoxidase/ b-galactosidase/
producer line CFU/ml (BHK-21) FFU/ml (BHK-21) FFU/ml (BHK/Bel-1) FFU/ml (BHK/Bel-1) FFU/ml (BHK-21) FFU/ml (BHLL)
RFF62/2N 2 1 105 6 1 103 1 1
RFF62/T 1 1 105 NDa 1 2
HSG11/22N 3 1 105 2 1 104 1.5 1 104 1 1
HSG11/11N 7 1 104 6 1 103 9 1 103 20 28
HSG11/3S 5 1 104 ND ND 1 1
HSG11/9S 1 1 105 3 1 103 5 1 103 1 1
BHK/HFV 5 1 104 2.5 1 105 3 1 105
Note. Assays were chosen to detect transfer of replication-defective vector genomes (columns A, B, and C), replication-competent virus (columns
E and F), or both (columns D). Column A indicates the puromycin-resistant colony-forming titer using BHK-21 target cells in supernatants harvested
from RFF62 producing clones. Columns B and C indicate the b-glucuronidase-positive focus-forming titer (using BHK-21 and BHK/Bel-1 target cells,
respectively) in supernatants harvested from HSG11 producing clones. Columns D and E indicate the viral antigen-positive focus-forming titer (using
BHK/Bel-1 and BHK-21 target cells, respectively) in vector supernatants. Column F indicates the b-galactosidase-positive focus-forming titer using
BHLL target cells.
a ND, not done.
Stability of vector genome expression ing inoculation of BHK-21 and BHLL indicator cells, re-
spectively. This replication-competent virus presumably
The results described above and in Table 1 were arose by recombination between the vector genomes
obtained using supernatants harvested from producer and the Bel-1 expression construct. Since the HFV env
cells within 2 months (approximately 15 passages) of and bel-1 genes overlap (Flu¨gel et al., 1987) there were
their initial cloning. To assess the stability of vector homologous sequences present in both constructs at the
expression, one producer clone (HSG11/22N) which 5* end of the bel-1 gene. The stretches of sequence
was initially helper virus-negative, was passaged for a homology between the integrated bel-1 gene and the
further 3 months (approximately 40 passages in total).
vectors RFF62 and HSG11 are 540 and 145 nt in length,
By this time, spontaneous cell fusion had diminished
respectively (Fig. 1). However, only RFF62 contains MLV-
(as compared to the freshly isolated clone). Supernatant
derived sequences (originally from pBabepuro) at the 3*
was then harvested and vector titer measured by X-
end of the inserted reporter gene. Therefore, nonhomolo-
gluc/NBT staining and helper virus tests were per-
gous recombination between vector and Bel-1 expres-formed using BHLL cells. The gusA transducing titer
sion construct would be required to reconstitute replica-had declined to 7 1 104 FFU/ml, and no helper virus
tion-competent virus in HSG 11 producing cells. Whetherwas detected in 2.5 ml of supernatant.
this recombination occurred between DNA molecules in
the producer cells, or by interstrand transfer during re-
DISCUSSION verse transcription is unknown.
Two previous studies have exploited vectors based onIn this study, cell lines producing replication-defective
the HFV genome for the transfer of marker genes inHFV-based vectors were constructed. In addition to their
vitro. Vectors have been constructed in which sequencespotential use in receptor identification, these vectors
between the 3* end of the bel-1 gene and the 3* LTRshould be useful starting reagents in experiments de-
were replaced with a variety of marker genes (Schmidtsigned to map cis-acting packaging sequences in the
and Rethwilm, 1995). Since gag, pol, env, and bel-1 genesHFV genome, an essential step in the development of
remained intact, these vectors remained replication-com-HFV as a potential vector for therapeutic gene transfer.
petent and were produced in similar titers to wild-typeFrom this study, it is evident that cis-acting sequences
HFV. Marker genes were encoded by RNAs that normallyrequired for vector expression or packaging are not lo-
express the viral Bet protein either as intact proteins orcated in the bel-genomic region.
as Bet-fusion proteins.Although most cell lines analyzed produced only-repli-
Complementary to these studies, replication-defectivecation-defective virus, some vector producing cell lines
vectors have been produced by insertion of marker genesalso produced low titers of virus which resulted in anti-
gen-positive foci or b-galactosidase-positive foci follow- in place of the HFV env gene (Russell and Miller, 1996).
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Ali, M., Taylor, G. P., Pitman, R. J., Parker, D., Rethwilm, A., Cheingsong-Vectors were packaged by transient cotransfection with
Popov, R., Weber, J. N., Bieniasz, P. D., Bradley, J., and McClure, M. O.an HFV gag/pol deletion mutant or wild-type virus. Even
(1996). No evidence of antibody to human foamy virus in widespread
when the defective trans-complementing virus was used, human populations. AIDS Res. Hum. Retroviruses 12, 1473–1483.
replication-competent helper virus was generated by re- Baunach, G., Maurer, B., Hahn, H., Kranz, M., and Rethwilm, A. (1993).
Functional analysis of human foamy virus accessory reading frames.combination and transfer of marker genes was accompa-
J. Virol. 67, 5411–5418.nied by similar titers of replication-competent HFV.
Bieniasz, P. D., Rethwilm, A. R., Pitman, R., Chrystie, I., and McClure,Foamy virus-based vectors may have several advan-
M. O. (1995). A comparative study of higher primate foamy viruses
tages over existing retroviral vectors for gene for in vivo including a new virus from a Gorilla. Virology 207, 217–228.
gene transfer: (i) The large packaging limit of foamy vi- Bieniasz, P. D., Weiss, R. A., and McClure, M. O. (1995). Cell cycle de-
pendence of foamy retrovirus infection. J. Virol. 65, 7295–7299.ruses (Schmidt and Rethwilm, 1995) means that larger
Cullen, B. (1992). Mechanism of action of regulatory proteins encodedgenes could be transferred than is currently possible
by complex retroviruses. Microbiol. Rev. 56, 375–394.with existing retroviral vectors, provided that elements
Enssle, J., Jordan, I., Maurer, B., and Rethwilm, A. (1996). Foamy virus
which are sufficient to direct genome encapsidation can reverse transcriptase is expressed independently from the Gag pro-
be identified. (ii) The recent finding that Pol proteins are tein. Proc. Natl. Acad. Sci. USA, in press.
Flugel, R. M., Rethwilm, A., Maurer, B., and Darai, G. (1987). Nucleotideexpressed independently of Gag (Enssle et al., 1996;
sequence analysis of the env gene and its flanking regions of theLochelt and Flugel, 1996; Yu et al., 1996) and that virus
human spumaretrovirus reveals two novel genes. EMBO J. 6, 2077–mutants functionally deficient in either Gag or Pol expres-
2084.
sion can complement each other in trans means that, in Herchenro¨der, O., Renne, R., Loncar, D., Cobb, E. K., Murthy, K. K.,
theory, packaging cell lines could be constructed where Schneider, J., Mergia, A., and Luciw, P. A. (1994). Isolation, cloning,
and sequencing of simian foamy viruses from chimpanzees (SFVcpz):Gag, Pol, and Env are synthesized from three separate
High homology to human foamy virus (HFV). Virology 201, 187–199.expression constructs. This would reduce the possibility
Herchenro¨der, O., Turek, R., Neumann-Haefelin, D., Rethwilm, A., andof generating replication-competent helper virus by re-
Schneider, J. (1995). Infectious proviral clones of chimpanzee foamy
combination in packaging cells. (iii) Since the HFV pro- virus (SFV-cpz) generated by long PCR reveal close functional relat-
moters are not competent to support virus replication in edness to human foamy virus. Virology 214, 685–689.
Keller, A., Partin, K. M., Lochelt, M., Bannert, H., Flugel, R. M., and Cul-the absence of Bel-1, vector constructs which essentially
len, B. R. (1991). Characterization of the transcriptional trans activatoreliminate the possibility of generating replication-compe-
of human foamy retrovirus. J. Virol. 65, 2589–2594.tent virus could be designed: U3 sequences in the 5*
Kupiec, J. J., Kay, A., Hayat, M., Ravier, R., Peries, J., and Galibert, F.
LTR would be replaced by a constitutive promoter, elimi- (1991). Sequence analysis of the simian foamy virus type 1 genome.
nating the requirement for Bel-1 for vector RNA synthesis. Gene 101, 185–194.
Lo¨chelt, M., Zentgraf, H., and Flugel, R. M. (1991). Construction of anSuch a vector packaged in a cell line engineered to ex-
infectious DNA clone of the full-length human spumaretrovirus ge-press Gag, Pol, and Env in trans under the control of
nome and mutagenesis of the Bel-1 gene. Virology 184, 43–54.heterologous promoters would constitute a safe gene
Lochelt, M., and Flugel, R. M. (1996). Human foamy virus pol gene is
transfer mechanism, since an essential gene for virus expressed as a pro-pol polyprotein and not as gag-pol fusion protein.
replication is completely excluded from the system. (iv) J. Virol. 62, 1120–1124.
Markowitz, D. G., Goff, S. P., and Bank, A. (1988). A safe packaging lineIn common with vectors based on oncoviruses, a major
for gene transfer: separating viral genes on two different plasmids.limitation of the use of foamy virus-based vectors is the
J. Virol. 62, 1120–1124.requirement for cell proliferation in optimal infection (Bie-
Maurer, B., Bannert, H., Darai, G., and Flugel, R. M. (1988). Analysis of
niasz et al., 1995; Russell and Miller, 1996), despite the the primary structure of the long terminal repeat and the gag and
presence of a peptide signal in HFV nucleocapsid protein pol genes of the human spumaretrovirus. J. Virol. 62, 1590–1597.
Miller, A. D. (1990). Retrovirus packaging cells. Hum. Gene Ther. 1, 5 –which directs nuclear transport of HFV Gag precursor
14.late in the viral life cycle; i.e., after genome integration
Miller, A. D. (1992). Retroviral vectors. Curr. Topics Microbiol. Immunol.and expression (Shliephake and Rethwilm, 1994). How-
158, 1–24.
ever, if efficient nuclear targeting of preintegration com- Morgenstern, J. P., and Land, H. (1990). Advanced mammalian gene
plexes can be achieved, then foamy viruses may be less transfer: High titre retroviral vectors and a complementary helper
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